Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
๐๐๐๐ฉ๐ข๐ง๐ ๐ฎ๐ฉ ๐ฐ๐ข๐ญ๐ก ๐ซ๐๐ฌ๐๐๐ซ๐๐ก: @EvidenceOpen secured a $1B valuation from Sequoia and partners with NEJM to help doctors keep up with exploding medical research. What this means for drug developers & healthcare. https://t.co/iwWmQtjgWL
.@OpenEvidence raises $75M to become the ChatGPT for doctors https://t.co/c2nRQG31hj @SiliconANGLE @Mike_Wheatley โPatients want to talk to a human doctor, not a robot, and they may not even appreciate their doctor chatting to a chatbot whileโฆโ - @holgermu https://t.co/7ePNKY3reC
.@OpenEvidence raises $75M to become the ChatGPT for doctors https://t.co/Zsxw2l9Ut6ย @SiliconANGLE @Mike_Wheatley โPatients want to talk to a human doctor, not a robot, and they may not even appreciate their doctor chatting to a chatbot whileโฆโ - @holgermu @constellationr
OpenEvidence, a healthtech startup based in Cambridge, MA, has successfully raised $75 million in its first outside funding round, led by Sequoia Capital. This funding round values the company at $1 billion. OpenEvidence aims to develop an AI-powered clinical assistant that allows physicians to query clinical questions and receive sourced answers based on trusted medical literature. The startup's goal is to become a resource akin to ChatGPT for doctors, enhancing their ability to keep up with the rapidly evolving medical research landscape. In addition to the funding, OpenEvidence has partnered with the New England Journal of Medicine (NEJM) to further support healthcare professionals in accessing relevant research.